#houston texas

1 story

#business #eli lilly #finance #foundayo #glp-1 drugs #manufacturing expansion #medicare coverage #novo nordisk #obesity treatment

Lilly claims one-third of new GLP-1 pill patients
Eli Lilly CEO says Foundayo is capturing a third of new oral GLP-1 patients as the company breaks ground on a six point five billion dollar Houston manufacturing facility.
CNBC · 1m